Literature DB >> 14517417

Phosphoinositide 3 kinase is critical for survival, mitogenesis and migration but not for differentiation of endothelial cells.

J H Qi1, T Matsumoto, K Huang, K Olausson, R Christofferson, L Claesson-Welsh.   

Abstract

Angiogenesis involves endothelial cell invasion and migration into the surrounding tissue where cells differentiate, to form new lumen-containing vessels. We have investigated the role of phosphoinositide 3-kinase (PI3-kinase) in vascular endothelial growth factor (VEGF)- and fibroblast growth factor (FGF)-induced angiogenesis. Angiogenesis in vivo in chick embryos was inhibited by treatment with the PI3-kinase inhibitors wortmannin and LY294002. Stimulation of primary bovine capillary endothelial (BCE) cells with FGF-2, VEGF-A(165), or a combination of the two induced PI3-kinase activity in vitro and subsequent activation of the serine/threonine kinase Akt. The combination of FGF-2 and VEGF-A(165) led to an additive response. Activation of PI3-kinase was strictly required for FGF-2- and VEGF-A(165)-induced migration and DNA synthesis of BCE cells. Tubular morphogenesis was unaffected by treatment with wortmannin or LY294002, but survival of the tubular structures was dependent on PI3-kinase activity. VEGF-A(165) and FGF-2 induced increased stability of the tubular structures in a synergistic manner. These data indicate that PI3-kinase activity is required for migration, mitogenicity and survival but not for differentiation of endothelial cells during angiogenesis.

Entities:  

Year:  1999        PMID: 14517417     DOI: 10.1023/a:1026565908445

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  10 in total

1.  Regulating angiogenesis at the level of PtdIns-4,5-P2.

Authors:  Eunok Im; Andrius Kazlauskas
Journal:  EMBO J       Date:  2006-04-20       Impact factor: 11.598

Review 2.  Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome.

Authors:  Ximing Li; Hongliang Cong
Journal:  Tex Heart Inst J       Date:  2009

3.  Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.

Authors:  Johan Kreuger; Taro Matsumoto; Maarten Vanwildemeersch; Takako Sasaki; Rupert Timpl; Lena Claesson-Welsh; Dorothe Spillmann; Ulf Lindahl
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

4.  EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.

Authors:  Tomonari Ojima; Hitoshi Takagi; Kiyoshi Suzuma; Hideyasu Oh; Izumi Suzuma; Hirokazu Ohashi; Daisuke Watanabe; Eri Suganami; Tomoaki Murakami; Masafumi Kurimoto; Yoshihito Honda; Nagahisa Yoshimura
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors.

Authors:  Doinita Serban; Jie Leng; David Cheresh
Journal:  Circ Res       Date:  2008-05-08       Impact factor: 17.367

6.  Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1.

Authors:  Melissa J Cudmore; Shakil Ahmad; Samir Sissaoui; Wenda Ramma; Bin Ma; Takeshi Fujisawa; Bahjat Al-Ani; Keqing Wang; Meng Cai; Fatima Crispi; Peter W Hewett; Eduard Gratacós; Stuart Egginton; Asif Ahmed
Journal:  Eur Heart J       Date:  2011-03-16       Impact factor: 29.983

7.  p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis.

Authors:  Taro Matsumoto; Ingela Turesson; Majlis Book; Pär Gerwins; Lena Claesson-Welsh
Journal:  J Cell Biol       Date:  2002-01-07       Impact factor: 10.539

8.  Pravastatin-induced proangiogenic effects depend upon extracellular FGF-2.

Authors:  Masayuki Shiota; Yuko Hikita; Yukiko Kawamoto; Hiromi Kusakabe; Masako Tanaka; Yasukatsu Izumi; Takafumi Nakao; Katsuyuki Miura; Yoshihiko Funae; Hiroshi Iwao
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

Review 9.  Molecular diversity of VEGF-A as a regulator of its biological activity.

Authors:  Jeanette Woolard; Heather S Bevan; Steven J Harper; David O Bates
Journal:  Microcirculation       Date:  2009-06-01       Impact factor: 2.628

10.  PI3 K/Akt/mTOR-mediated translational control regulates proliferation and differentiation of lineage-restricted RoSH stem cell lines.

Authors:  Jianwen Que; Qizhou Lian; Reida M El Oakley; Bing Lim; Sai-Kiang Lim
Journal:  J Mol Signal       Date:  2007-09-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.